FIG 6.

Synergy of double combinations of oseltamivir and MBX2329 or MBX2546 carboxylate against 2009 pandemic influenza A virus strain A/California/10/2009 (H1N1). Shown are plots of synergy volume for double combinations of oseltamivir (at 0.1 μg/ml) and MBX2329 (A) or MBX2546 (B) against 2009 pandemic influenza A virus strain A/California/10/2009 (H1N1), as determined by a neutral red assay. Synergy volume data are presented as the means of 18 replicates from 6 experiments with 95% confidence intervals.